Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients

BACKGROUND: Cetuximab and bevacizumab reportedly improve the survival of patients with metastatic colorectal cancer (mCRC), but their most effective sequence of administration is unknown. The aim of this study was to compare the survival of patients with mCRC treated with cetuximab after bevacizumab...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Sato, Yasuyoshi, Matsusaka, Satoshi, Suenaga, Mitsukuni, Shinozaki, Eiji, Mizunuma, Nobuyuki
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2015
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648607/
https://ncbi.nlm.nih.gov/pubmed/26648737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S89241
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker